Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis/ Eczema”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04872101
What this trial is testing

Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)

Who this might be right for
Chronic Hand Eczema
LEO Pharma 473
Testing effectiveness (Phase 2)Study completedNCT01902836
What this trial is testing

Efficacy Study of Dialyzed Leukocytes Extracts to Treat Paediatric Moderate Atopic Dermatitis

Who this might be right for
Childhood Atopic Dermatitis
National Polytechnic Institute, Mexico 58
Early research (Phase 1)Study completedNCT06673654
What this trial is testing

A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Sun Pharmaceutical Industries, Inc. 476
Not applicableStudy completedNCT04763512
What this trial is testing

Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)

Who this might be right for
Atopic DermatitisSkin Condition
Société des Produits Nestlé (SPN) 200
Post-approval studies (Phase 4)Study completedNCT00925730
What this trial is testing

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

Who this might be right for
Atopic Dermatitis
Novartis 20
Testing effectiveness (Phase 2)Ended earlyNCT00927212
What this trial is testing

Topical Application of AS101 for the Treatment of Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
BioMAS Ltd 5
Large-scale testing (Phase 3)Study completedNCT02395133
What this trial is testing

Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 422
Large-scale testing (Phase 3)Study completedNCT03160885
What this trial is testing

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)

Who this might be right for
Atopic Dermatitis
LEO Pharma 794
Early research (Phase 1)Study completedNCT04271514
What this trial is testing

A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
RAPT Therapeutics, Inc., a member of the GSK plc group of companies 103
Not applicableStudy completedNCT07017348
What this trial is testing

Assessment of Clinical, Biological and Biometrological Parameters in Adults Subjects With Atopic Dermatitis

Who this might be right for
Atopic DermatitisHealthy
Pierre Fabre Dermo Cosmetique 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07762833
What this trial is testing

Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Galderma R&D 240
Testing effectiveness (Phase 2)Study completedNCT01098734
What this trial is testing

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Who this might be right for
Dermatitis, Atopic
Welichem Biotech Inc. 148
Large-scale testing (Phase 3)Not Yet RecruitingNCT07377838
What this trial is testing

Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
EHL Bio Co., Ltd. 286
Testing effectiveness (Phase 2)Study completedNCT05014438
What this trial is testing

BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Bristol-Myers Squibb 17
Not applicableStudy completedNCT02594969
What this trial is testing

The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
University of California, Davis 20
Not applicableLooking for participantsNCT05721937
What this trial is testing

How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

Who this might be right for
Atopic Dermatitis
Pfizer 400
Testing effectiveness (Phase 2)Ended earlyNCT03055195
What this trial is testing

Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 34
Not applicableLooking for participantsNCT05689151
What this trial is testing

Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic DermatitisEczema
Pfizer 183
Testing effectiveness (Phase 2)Study completedNCT05158023
What this trial is testing

Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
ASLAN Pharmaceuticals 302
Testing effectiveness (Phase 2)Study completedNCT05432596
What this trial is testing

Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Aclaris Therapeutics, Inc. 250
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation